Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Paid-in- Capital
Accumulated Other Comprehensive Income / (Loss)
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2021   491,911      
Beginning balance at Dec. 31, 2021 $ 1,111,217 $ 491,911 $ 105,629 $ (16,411) $ 530,088
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 73,766       73,766
Other comprehensive income / (loss), net of tax:          
Foreign currency translation adjustments 3,127     3,127  
Unrealized gain (loss) on available for sale securities (590)     (590)  
Cash dividends (49,205)       (49,205)
Stock compensation (in shares)   757      
Stock compensation 6,138 $ 757 5,381    
Employee stock buybacks (in shares)   (207)      
Employee stock buybacks (6,434) $ (207) (6,227)    
Ending balance (in shares) at Mar. 31, 2022   492,461      
Ending balance at Mar. 31, 2022 1,138,019 $ 492,461 104,783 (13,874) 554,649
Beginning balance (in shares) at Dec. 31, 2022   492,448      
Beginning balance at Dec. 31, 2022 1,267,197 $ 492,448 119,242 (31,562) 687,069
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 88,234       88,234
Other comprehensive income / (loss), net of tax:          
Foreign currency translation adjustments 97     97  
Unrealized gain (loss) on available for sale securities 162     162  
Cash dividends (64,053)       (64,053)
Stock compensation (in shares)   601      
Stock compensation 5,947 $ 601 5,346    
Employee stock buybacks (in shares)   (262)      
Employee stock buybacks (9,832) $ (262) (9,570)    
Ending balance (in shares) at Mar. 31, 2023   492,787      
Ending balance at Mar. 31, 2023 $ 1,287,752 $ 492,787 $ 115,018 $ (31,303) $ 711,250